# Supplement - Discovering the role of YES1 in triple negative breast cancer

> **NIH NIH R01** · CLEVELAND CLINIC LERNER COM-CWRU · 2024 · $365,768


## Key facts

- **NIH application ID:** 11034309
- **Project number:** 3R01CA257502-04S2
- **Recipient organization:** CLEVELAND CLINIC LERNER COM-CWRU
- **Principal Investigator:** RUTH A. KERI
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $365,768
- **Award type:** 3
- **Project period:** 2024-07-01 → 2025-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11034309

## Citation

> US National Institutes of Health, RePORTER application 11034309, Supplement - Discovering the role of YES1 in triple negative breast cancer (3R01CA257502-04S2). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/11034309. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*